THE USE OF TNF-ALPHA ANTAGONIST AS DRUGS FOR THE TREATMENT OF PATIENTS WITH SEPSIS AND WITHOUT SUFFERING FROM TOTAL ORGAN FAILURE

Details for Australian Patent Application No. 2003210300 (hide)

Owner ABBOTT GMBH AND CO. KG

Inventors VAN METER, Lori, L.; ABDELGHANY, Heidrun, Dorothea; BARCHUK, William, T.; DAUM, Lothar; EISELSTEIN, Jurgen; KAUL, Martin

Pub. Number AU-A-2003210300

PCT Number PCT/EP03/01631

PCT Pub. Number WO2003/070274

Priority 10/079,776 19.02.02 US

Filing date 18 February 2003

Wipo publication date 9 September 2003

International Classifications

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 031/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 016/24 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 10/079,776 19.02.02 US

9 October 2003 Application Open to Public Inspection

  Published as AU-A-2003210300

4 November 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003210301-WHEEL HUB ASSEMBLY

2003210299-DIRECTIONAL MICROPHONE ARRANGEMENT